Serono Broadens Research Pipeline With ZymoGenetics Alliance

Serono will pay over $81 mil. upfront for access to ZymoGenetics’ therapeutic protein research. The deal includes a license to products based on three proteins that could expand Serono’s presence in inflammation and autoimmune disease.